|
MechanismIGF-1R antagonists |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhaseWithdrawn |
First Approval Ctry. / Loc.US |
First Approval Date12 Dec 2005 |
Long-Term Safety and Efficacy Outcomes Following Previously Administered Short-Term Treatment with SHP607 in Extremely Premature Infants - Footsteps
100 Clinical Results associated with Premacure AB
0 Patents (Medical) associated with Premacure AB
100 Deals associated with Premacure AB
100 Translational Medicine associated with Premacure AB